When a private hospital becomes a public health wager
In Nairobi, some decisions cannot be measured in profits alone. They are judged by whether they open the door to patients who had no nearby option, or no option at all. In Kenya’s health system, where cancer remains a heavy burden for households, building a specialist centre is as much an investment as a service to the city and the country. Kenya still records around 44,726 new cancer cases a year, according to the IARC/WHO GLOBOCAN 2022 country fact sheet.
The issue takes on particular significance in Nairobi, in a member country of the East African Community, where access to specialist care remains highly unequal between the capital, major cities and more remote areas. Kenya’s Ministry of Health says it launched the Social Health Authority, the health coverage body that replaced the previous funding mechanisms, with benefits specifically for cancer. It also announced a gradual expansion of oncology coverage in 2025.
The gamble taken by a Kenyan oncologist
Dr Catherine Nyongesa is one of the leading figures in this story. The centre she founded in Nairobi, Texas Cancer Centre, says it was established in June 2010 to provide specialist cancer care. Her professional profile describes her as a clinical oncologist and radiotherapist with more than 20 years’ experience, and as Kenya’s first female radiotherapist.
Her background helps explain her decision. In several interviews, she has said that her sister’s illness, a gynaecological cancer, exposed her early on to the cost, scarcity of specialists and difficulty of finding a suitable place for treatment. The experience drove her to build a facility where care would no longer be a luxury. Kenyan media and the centre’s official profile also confirm that she worked for many years at Kenyatta National Hospital, Nairobi’s major public referral hospital.
The original account refers to a loan of 100 million Kenyan shillings, equivalent to about $77,000 at the exchange rate used in the source text. The funding helped launch the centre’s infrastructure. The idea initially met with resistance from bankers, because a specialist hospital, particularly one serving patients on modest incomes, does not offer the quick returns expected by conventional lenders. Nyongesa’s decision nevertheless shows that a healthcare facility can be designed as a sustainable business without being driven solely by profit.
What health coverage changes
In Kenya, the debate is not only about whether specialist centres exist. It is about how care is paid for. The Ministry of Health has said the Social Health Authority is intended to protect families from catastrophic expenses and include cancer care in its package of services. In 2025, it announced that cancer coverage would rise to 800,000 shillings per patient from 1 December, up from a previous allocation of 550,000 shillings.
This change matters, but it does not solve everything. Cancer care also depends on equipment, medicines, early diagnosis and the availability of specialists. In February 2026, the ministry said it was working to strengthen regional centres to bring services closer to communities. This is a crucial issue for families outside Nairobi, who still have to contend with transport costs, delays and interruptions to their care.
In this context, private facilities such as Texas Cancer Centre play a dual role. They ease the pressure on an overstretched public system. They also serve as a link to faster care in urban areas. For patients, this can mean shorter waits and greater proximity. For households, it can reduce reliance on family savings, asset sales or informal fundraisers, which often accompany a cancer diagnosis in East Africa.
A Kenyan story, but an African challenge
Catherine Nyongesa’s journey goes beyond an individual story. It says something broader about African health systems: medical innovation does not come only from governments or donors, but also from local players who combine clinical expertise, entrepreneurship and social roots. In Kenya, this momentum is part of a wider strategy of health reform, pooled funding and decentralisation of specialist care.
It also serves as a reminder that the fight against cancer on the continent cannot be reduced to prevention alone. It must include radiotherapy machines, laboratories, chemotherapy rooms, health insurance and specialist training. East Africa is watching these issues closely, because decisions made in Nairobi also influence professional practice, referral networks and care pathways across the region. The question now is whether Kenya can turn its health coverage announcements into real, measurable and lasting access for patients.



